Back
HUTCHMED (China) Quote, Financials, Valuation and Earnings
Sponsored
HCM
Sponsored
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Buy
67
HCM
HUTCHMED (China)
Last Price:
16.95
Seasonality Move:
2.42%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.HUTCHMED (China) Price Quote
$16.95
+0.01 (+2.79%)
(Updated: April 23, 2024 at 5:00 AM ET)
HUTCHMED (China) Key Stats
Buy
67
HUTCHMED (China) (HCM)
is a Buy
Day range:
$16.69 - $17.02
52-week range:
$10.68 - $20.73
Dividend yield:
0%
P/E ratio:
28.23
P/S ratio:
3.51
P/B ratio:
3.96%
Volume:
146.7K
Avg. volume:
174.3K
1-year change:
3.61%
Market cap:
$2.9B
Revenue:
$838M
EPS:
$0.55
How Much Does HUTCHMED (China) Make?
-
How Much Are HUTCHMED (China)'s Sales Annually?
HCM Revenues are $838M -
How Much Profit Does HUTCHMED (China)'s Make A Year?
HCM net income is $100.8M
Is HUTCHMED (China) Growing As A Company?
-
What Is HUTCHMED (China)'s Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.52% -
What Is HUTCHMED (China)'s EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
HUTCHMED (China) Stock Price Performance
-
Did HUTCHMED (China) Stock Go Up Last Month?
HUTCHMED (China) share price went up by 3.36% last month -
Did HCM's Share Price Rise Over The Last Year?
HCM share price rose by 3.61% over the past 1 year
What Is HUTCHMED (China) 52-Week High & Low?
-
What Is HUTCHMED (China)’s 52-Week High Share Price?
HUTCHMED (China) has traded as high as $20.73 over the past 52 weeks -
What Is HUTCHMED (China)’s 52-Week Low Share Price?
HUTCHMED (China) has traded as low as $10.68 over the past 52 weeks
HUTCHMED (China) Price To Free Cash Flow
-
Is HUTCHMED (China) Stock Overvalued?
HUTCHMED (China) is trading at a price to free cash flow ratio of 15.78 -
Is HUTCHMED (China) Stock Undervalued?
HUTCHMED (China) EV to Free Cash Flow ratio is 11.24 -
What Is HUTCHMED (China)’s Price Earnings Growth Ratio?
HCM PEG ratio is 0.00 -
Is HUTCHMED (China) Trading At A Premium To Earnings?
HUTCHMED (China) EV to EBIT ratio is 35.52
Is It Risky To Buy HUTCHMED (China)?
-
How Much Debt Does HUTCHMED (China) Have?
Total long term debt quarterly is $79.3M -
How Much Cash Does HUTCHMED (China) Have?
Cash and short term investments quarterly total is $886.3M -
What Is HUTCHMED (China)’s Book Value Per Share?
Book value per share is 4.28
Is HUTCHMED (China) Cash Flow Positive?
-
What Is HCM Cash Flow From Operations?
Cash flow from operations (TTM) is $219.3M -
What Is HUTCHMED (China)’s Cash Flow From Financing?
Cash flow from financing (TTM) is $48.7M -
What Is HUTCHMED (China)’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$291.1M
HUTCHMED (China) Return On Invested Capital
-
Is Management Doing A Good Job?
HCM return on invested capital is 13.04% -
What Is HUTCHMED (China) Return On Assets?
ROA measures how assets are converting to revenues and is 8.38% -
What Is HCM Return On Equity?
ROE is a measure of profitability and is 13.87%
HUTCHMED (China) Earnings Date & Stock Price
-
What Is HUTCHMED (China)'s Stock Price Today?
A single share of HCM can be purchased today for 16.94 -
What Is HUTCHMED (China)’s Stock Symbol?
HUTCHMED (China) trades on the nasdaq under the ticker symbol: HCM -
When Is HUTCHMED (China)’s Next Earnings Date?
The next quarterly earnings date for HUTCHMED (China) is scheduled on July 31, 2024 -
When Is HCM's next ex-dividend date?
HUTCHMED (China)'s next ex-dividend date is June 18, 2020 -
How To Buy HUTCHMED (China) Stock?
You can buy HUTCHMED (China) shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
HUTCHMED (China) Competitors
-
Who Are HUTCHMED (China)'s Competitors?
Below is a list of companies who compete with HUTCHMED (China) or are related in some way:
HUTCHMED (China) Dividend Yield
Data Unavailable
HUTCHMED (China) Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 51.52% | 0% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 29.06 |
Upside from Last Price: | 71.54% |